Companies /Healthcare
Organon & Company
NYSE: OGN Drug Manufacturers - General
$13.75
▲ $0.00 (+0.00%) today
Markets closed · 4:17pm ET

Organon & (OGN) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
75%
EPS beat rate
+3.91%
Avg. EPS surprise
Consecutive EPS misses
OGN vs Market · 30-day return after each reportOGNS&P 500
−10%0%+10%+20%−0.1%+6.7%Q1 25+23.6%+3.1%Q2 25−4.5%+1.1%Q3 25−9.5%−1.5%Q4 25
−10%0%+10%+20%Q1 25Q2 25Q3 25Q4 25
OGN EPS Trend · estimate vs actualEstimateActual
$0.00$0.30$0.60$0.90$0.89$1.02Q1 25$0.94$1.00Q2 25$0.93$1.01Q3 25$0.73$0.63Q4 25
$0.00$0.30$0.60$0.90Q1 25Q2 25Q3 25Q4 25
OGN Revenue Trend · estimate vs actualEstimateActual
$0$500.0M$1.0B$1.5B$1.5B$1.5BQ1 25$1.6B$1.6BQ2 25$1.6B$1.6BQ3 25$1.5B$1.5BQ4 25
$0$500.0M$1.0B$1.5BQ1 25Q2 25Q3 25Q4 25

How Often Does Organon & Beat Earnings Estimates?

Organon & beat EPS estimates in 3 of its last 4 reported quarters.

OGN quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q4 2025 $0.63 est. $0.73 −13.34% $1.5B est. $1.5B −0.51%
Q3 2025 $1.01 est. $0.93 +8.45% $1.6B est. $1.6B +1.68%
Q2 2025 $1.00 est. $0.94 +6.36% $1.6B est. $1.6B +2.32%
Q1 2025 $1.02 est. $0.89 +14.17% $1.5B est. $1.5B +0.32%

Figures from SEC filings and company reports. Not investment advice.